Product Description
Overall, the global coronary atherectomy market was valued at nearly $374 million in 2025. This is expected to increase over the forecast period at a CAGR of 4.1% to reach nearly $496 million.
The full report suite on the global market for coronary atherectomy includes laser atherectomy and mechanical atherectomy.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Coronary Atherectomy Market Trends
The ongoing occurrence of complex lesions requiring coronary atherectomy will continue to support market growth. Although these challenging cases represent a more specialized segment, their consistent presence provides a stable foundation and key opportunity for market expansion.
Global Coronary Atherectomy Market Share Insights
- Boston Scientific held the leading position in the atherectomy device market in 2025, primarily due to its strong presence in the mechanical atherectomy segment. While the company continues to remain competitive in this area, its overall market share has declined in recent years.
- Abbott ranked as the second-largest competitor in the atherectomy device market in 2025, offering the Diamondback 360® orbital atherectomy system. With a broad presence across multiple interventional cardiology segments, the company is expected to maintain, rather than significantly expand, its market share over the forecast period.
- Philips was a notable participant in the atherectomy device market in 2025, offering the Neximer and CVX-300 Excimer laser systems. The company is expected to gain modest market share as it continues to invest in enhancing and expanding its product portfolio.
Global Coronary Atherectomy Market Segmentation Summary
- Coronary Atherectomy Market – Further Segmented Into:
- Device Type: Mechanical Atherectomy, and Laser Atherectomy.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
